Haematologica (Sep 2019)
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party
- Ali Bazarbachi,
- Myriam Labopin,
- Giorgia Battipaglia,
- Azedine Djabali,
- Jakob Passweg,
- Gerard Socié,
- Edouard Forcade,
- Didier Blaise,
- Patrice Chevallier,
- Corentin Orvain,
- Jan J. Cornelissen,
- William Arcese,
- Sylvain Chantepie,
- Khowla Hashaishi,
- Jean El Cheikh,
- Michael Medinger,
- Jordi Esteve,
- Arnon Nagler,
- Mohamad Mohty
Affiliations
- Ali Bazarbachi
- Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon;Department of Cell Biology, Anatomy and Physiological Sciences, American University of Beirut, Beirut, Lebanon
- Myriam Labopin
- Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hôpital Saint Antoine, Université Pierre and Marie Curie, INSERM, UMRs 938, Paris, France
- Giorgia Battipaglia
- Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hematology Department, Federico II University of Naples, Naples, Italy
- Azedine Djabali
- Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France
- Jakob Passweg
- University Hospital, Hematology, Basel, Switzerland
- Gerard Socié
- Hôpital Saint Louis, Department of Hematology – BMT, Paris, France
- Edouard Forcade
- CHU Bordeaux Hôpital Haut-leveque, Pessac, France
- Didier Blaise
- Programme de Transplantation and Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France
- Patrice Chevallier
- CHU Nantes, Department D’Hematologie, Nantes, France
- Corentin Orvain
- CHRU, Service des Maladies du Sang, Angers, France
- Jan J. Cornelissen
- Department of Hematology, Rotterdam, the Netherlands
- William Arcese
- Tor Vergata University of Rome, Stem Cell Transplant Unit, Policlinico Universitario Tor Vergata, Rome, Italy
- Sylvain Chantepie
- CHU CAEN, Institut d’Hématologie de Basse-Normandie, Caen, France
- Khowla Hashaishi
- Acute Leukemia Working Party of EBMT, Paris, France
- Jean El Cheikh
- Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
- Michael Medinger
- University Hospital, Hematology, Basel, Switzerland
- Jordi Esteve
- Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
- Arnon Nagler
- Acute Leukemia Working Party of EBMT, Paris, France;Chaim Sheba Medical Center, Tel-Hashomer, Israel
- Mohamad Mohty
- Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hôpital Saint Antoine, Université Pierre and Marie Curie, INSERM, UMRs 938, Paris, France
- DOI
- https://doi.org/10.3324/haematol.2018.211615
- Journal volume & issue
-
Vol. 104,
no. 9
Abstract
No abstracts available.